Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
阿利西尤单抗降低脂蛋白(a)水平可降低心血管事件总负担,且该作用独立于降低低密度脂蛋白胆固醇水平:ODYSSEY OUTCOMES试验
期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehaa649
Szarek, Michael; Bittner, Vera A; Aylward, Philip; Baccara-Dinet, Marie; Bhatt, Deepak L; Diaz, Rafael; Fras, Zlatko; Goodman, Shaun G; Halvorsen, Sigrun; Harrington, Robert A; Jukema, J Wouter; Moriarty, Patrick M; Pordy, Robert; Ray, Kausik K; Sinnaeve, Peter; Tsimikas, Sotirios; Vogel, Robert; White, Harvey D; Zahger, Doron; Zeiher, Andreas M; Steg, Ph Gabriel; Schwartz, Gregory G